Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling

BackgroundProgressive remodeling of the left ventricle (LV) following myocardial infarction (MI) can lead to congestive heart failure, but the underlying initiation factors remain poorly defined. The objective of this study, accordingly, was to determine the key factors and elucidate the regulatory mechanisms of LV remodeling using integrated computational and experimental approaches.ResultsBy examining the extracellular matrix (ECM) gene expression and plasma analyte levels in C57/BL6J mice LV post-MI and ECM gene responses to transforming growth factor (TGF-β1) in cultured cardiac fibroblasts, we found that key factors in LV remodeling included macrophages, fibroblasts, transforming growth factor-β1, matrix metalloproteinase-9 (MMP-9), and specific collagen subtypes. We established a mathematical model to study LV remodeling post-MI by quantifying the dynamic balance between ECM construction and destruction. The mathematical model incorporated the key factors and demonstrated that TGF-β1 stimuli and MMP-9 interventions with different strengths and intervention times lead to different LV remodeling outcomes. The predictions of the mathematical model fell within the range of experimental measurements for these interventions, providing validation for the model.ConclusionsIn conclusion, our results demonstrated that the balance between ECM synthesis and degradation, controlled by interactions of specific key factors, determines the LV remodeling outcomes. Our mathematical model, based on the balance between ECM construction and destruction, provides a useful tool for studying the regulatory mechanisms and for predicting LV remodeling outcomes.

[1]  Philip K. Maini,et al.  A mathematical model for fibro-proliferative wound healing disorders , 1996 .

[2]  Martin Abel,et al.  In vitro binding of matrix metalloproteinase‐2 (MMP‐2), MMP‐9, and bacterial collagenase on collagenous wound dressings , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[3]  Min Zhang,et al.  Role of reactive oxygen species in myocardial remodeling , 2007, Current heart failure reports.

[4]  Min Huang,et al.  IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. , 2002, The Journal of clinical investigation.

[5]  E. Leroy,et al.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. , 1974, The Journal of clinical investigation.

[6]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[8]  P. Libby,et al.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.

[9]  Adeline Koh,et al.  Osteopontin Expression Is Required for Myofibroblast Differentiation , 2008, Circulation research.

[10]  H. V. Waugh,et al.  Modeling the effects of treating diabetic wounds with engineered skin substitutes , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[11]  Mansur Ahmad,et al.  Effects of transforming growth factor-beta 1 (TGF-beta1) on in vitro mineralization of human osteoblasts on implant materials. , 2003, Biomaterials.

[12]  Merry L Lindsey,et al.  Altered fibroblast function following myocardial infarction. , 2005, Journal of molecular and cellular cardiology.

[13]  J A Sherratt,et al.  Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring. , 2000, Journal of theoretical biology.

[14]  Thomas K Borg,et al.  Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. , 2007, American journal of physiology. Heart and circulatory physiology.

[15]  Merry L Lindsey,et al.  Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. , 2005, Cardiovascular research.

[16]  W A Hsueh,et al.  Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. , 1996, The Journal of clinical investigation.

[17]  H. V. Waugh,et al.  Macrophage Dynamics in Diabetic Wound Dealing , 2006, Bulletin of mathematical biology.

[18]  Tudor C. Poerner,et al.  Time-Dependent Changes in the Plasma Concentration of Matrix Metalloproteinase 9 after Acute Myocardial Infarction , 2003, Cardiology.

[19]  K. Mucha,et al.  Proteolytic Enzymes Activities in Patients After Myocardial Infarction Correlate with Serum Concentration of TGF-β , 2004, Inflammation.

[20]  Shawn Cowper,et al.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood. , 2004, The international journal of biochemistry & cell biology.

[21]  C. Haslett,et al.  In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. , 1996, Journal of immunology.

[22]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[23]  J A Sherratt,et al.  A mathematical model for fibro-proliferative wound healing disorders. , 1996, Bulletin of mathematical biology.

[24]  L. Field,et al.  Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. , 2000, Circulation research.

[25]  Subbiah Vairamuthu,et al.  Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats , 2005, Molecular and Cellular Biochemistry.

[26]  Stephane Heymans,et al.  Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. , 2006, Cardiovascular research.

[27]  J. Rumberger,et al.  Ventricular dilatation and remodeling after myocardial infarction. , 1994, Mayo Clinic proceedings.

[28]  D. Danielpour,et al.  Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. , 1993, The Journal of clinical investigation.

[29]  Massimo Coletta,et al.  Enzymatic processing of collagen IV by MMP‐2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains , 2006, Protein science : a publication of the Protein Society.

[30]  Lu Fang,et al.  Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. , 2010, International journal of cardiology.

[31]  M. Harmsen,et al.  Stem cell-related cardiac gene expression early after murine myocardial infarction. , 2007, Cardiovascular research.

[32]  A. Hansson,et al.  Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of L‐lactate , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[33]  S. Mai,et al.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. , 1999, The American journal of pathology.

[34]  Richard T. Lee,et al.  Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. , 2006, American journal of physiology. Heart and circulatory physiology.

[35]  Avner Friedman,et al.  Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.

[36]  Merry Lindsey,et al.  Matrix-Dependent Mechanism of Neutrophil-Mediated Release and Activation of Matrix Metalloproteinase 9 in Myocardial Ischemia/Reperfusion , 2001, Circulation.

[37]  Peter Atkins,et al.  Physical Chemistry for the Life Sciences , 2005 .

[38]  I. Darby,et al.  Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. , 1997, International Journal of Biochemistry and Cell Biology.

[39]  A. Dart,et al.  Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. , 2005, Cardiovascular research.

[40]  Leslie L. Clark,et al.  Specific Temporal Profile of Matrix Metalloproteinase Release Occurs in Patients After Myocardial Infarction: Relation to Left Ventricular Remodeling , 2006, Circulation.

[41]  P. Zahradka,et al.  Novel role for osteopontin in cardiac fibrosis. , 2008, Circulation research.

[42]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[43]  Roger Markwald,et al.  Periostin: more than just an adhesion molecule. , 2007, Circulation research.

[44]  C. Daub,et al.  BMC Systems Biology , 2007 .

[45]  P. Whittaker,et al.  Collagen and ventricular remodeling after acute myocardial infarction: concepts and hypotheses , 1997, Basic Research in Cardiology.

[46]  J. Paulauskis,et al.  Differential screening identifies genetic markers of monocyte to macrophage maturation , 1996, Journal of leukocyte biology.

[47]  C H Wu,et al.  Evidence for pretranslational regulation of collagen synthesis by procollagen propeptides. , 1986, The Journal of biological chemistry.

[48]  Stefan Frantz,et al.  Healing after myocardial infarction. , 2005, Cardiovascular research.

[49]  B. Schaan,et al.  Serum transforming growth factor beta-1 ( TGF-beta-1 ) levels in diabetic patients are not associated with pre-existent coronary artery disease , 2007 .

[50]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  H. Sengeløv,et al.  Isolation and characterization of gelatinase granules from human neutrophils. , 1994, Blood.

[52]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[53]  Leong L Ng,et al.  Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. , 2007, European heart journal.

[54]  A. Popel,et al.  A Biochemical Model of Matrix Metalloproteinase 9 Activation and Inhibition* , 2007, Journal of Biological Chemistry.

[55]  A. Telser,et al.  THE MACROPHAGE, 2ND EDITION , 2003 .

[56]  Hai-Chao Han,et al.  Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms , 2008, Experimental Gerontology.

[57]  Rogelio Zamilpa,et al.  Proteomic analysis identifies in vivo candidate matrix metalloproteinase‐9 substrates in the left ventricle post‐myocardial infarction , 2010, Proteomics.

[58]  V. Roger,et al.  Heart failure after myocardial infarction: clinical presentation and survival , 2005, European journal of heart failure.

[59]  Lu Fang,et al.  Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.

[60]  Emmanouil D Karagiannis,et al.  A Theoretical Model of Type I Collagen Proteolysis by Matrix Metalloproteinase (MMP) 2 and Membrane Type 1 MMP in the Presence of Tissue Inhibitor of Metalloproteinase 2*[boxs] , 2004, Journal of Biological Chemistry.

[61]  Fang Yang,et al.  Myocardial Infarction and Cardiac Remodelling in Mice , 2002, Experimental physiology.

[62]  F. Hamada,et al.  Inhibition of Cytokine-induced Matrix Metalloproteinase 9 Expression by Peroxisome Proliferator-activated Receptor α Agonists Is Indirect and Due to a NO-mediated Reduction of mRNA Stability* , 2002, The Journal of Biological Chemistry.

[63]  Melissa Joy Loftis,et al.  Effects of collagen density on cardiac fibroblast behavior and gene expression , 2003, Journal of cellular physiology.

[64]  Loredana Moro,et al.  Loss of BRCA2 promotes prostate cancer cell invasion through up‐regulation of matrix metalloproteinase‐9 , 2008, Cancer science.

[65]  K. Weber,et al.  Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. , 1998, Annals of medicine.

[66]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[67]  H. Folkesson,et al.  Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. , 2006, American journal of physiology. Heart and circulatory physiology.

[68]  Min Huang,et al.  IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis , 2002 .